Main > > >ANTIBIOTICS. *
Azithromycin Injection. Brand. (U)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.10.
Azithromycin.2H2O API. (E)
(*) Company; Patents & Web-Site Availa-
ble on Request.
UpDate: 2018. 04.09.
Azithromycin.H2O IR Tablet. Brand. (I)
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.09.
Cefdinir Capsules. Brand. (U)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.09.
Cefepime.HCl Injection, Powder, For Solution.
(*) Company : Bristol-Myers Squibb.
www.bms.com
Patents : Expired.
TradeMark: Maxipime.
UpDate: 2018. 04.10.
Ceftriaxone Na for Injection.
(*) Company : Roche.
Patent : Expired.
TradeMark: Rocephin.
UpDate: 2018. 04.10.
Clindamycin Injection. (U)
USA Approval & Launch Date: 2017. 06.07.
(*) Company & PR Web-Site Available on
Request.
UpDate: 2018. 04.10.
DalfoPristin+QuinuPristin. Brand. (U)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.10.
Daptomycin for Injection. Generics.
USA Approval & Launch Date: 2018. 04.12.
(*) Company: Fresenius Kabi.
www.fresenius-kabi.com
UpDate: 2018. 04.13.
DoxyCycline.
(*) Company : Pfizer.
Patent : Expired.
TradeMark: Vibramycin
UpDate: 2018. 04.10.
Erythromycin Ethyl Succinate for Oral Suspension. Generic.
USA Launch Date: 2016. 09.27.
(*) Company: Ani Pharma.
www.anipharmaceuticals.com
UpDate: 2018. 04.09.
Erythromycin Topical Solution 2%.
Generic. (U)
USA Approval Date: 2017. 11.21.
(*) Company Available on Request.
UpDate: 2018. 04.10.
Gentamicin Injection. Generic. (U)
Type: AminoGlycoside
CA Approval Date: 2016. 08.23.
(*) Company Available on Request.
UpDate: 2018. 04.10.
Linezolid Oral.
(*) Company : Pfizer.
Patent : Expiration: 2016. 03.05.
TradeMark: Zyvox
UpDate: 2018. 04.10.
Moxifloxacin.HCl Injection. Brand. (U)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.10.
Moxifloxacin.HCl Injection. Generic.
USA Launch Date: 2017. 10.05.
(*) Company : Mylan.
UpDate: 2018. 04.09.
Nemonoxacin Oral Formulation. (T)
Non-F Quinolone.
CN Approval Date: 2016. 06.13.
(*) Companies; Patent & TradeMark Avai
lable on Request.
UpDate: 2018. 04.09.
Neomycin Tablet. (U)
Class: AminoGlycoside.
USA Approval Date: 2016. 06.13.
(*) Company Available on Request.
UpDate: 2018. 04.10.
Oxacillin Injection.
USA Approval Date: 2017. 08.07.
(*) Company : Wockhardt Ltd.
www.wockhardt.com
UpDate: 2018. 04.09.
Tetracycline.HCl Capsules.
USA Launch Date: 2019. 02.12.
(*) Company: Breckenridge Pharmaceutical
UpDate: 2019. 02.13.
TigeCycline Injection.
(*) Company : Pfizer.
Patent : Expiration 2015. 05.31.
TradeMark: Tygacil
UpDate: 2018. 04.10.
Vancomycin.HCl PreMixed Injection
USA Approval Date: 2019. 02.19.
(*) Company; Patents & PR Web-Site
Available on Request
UpDate: 2019. 02.20.
>ANTIBIOTICS. *'s products
This section has no products